Equity Capital Markets

Our Equity Capital Markets activities benefit from both our equity sales department, with its strong record of placements and first-class equity research, and our Corporate Finance department which has sucessfully excuted numerous capital markets transactions. We provide support by

  • taking on leading mandates for IPOs, capital increases and structured placements
  • participating in underwriting syndicates for large, international placements
  • advising issuers and companies during capital market transactions
  • assisting public purchase offers
  • preparing fairness opinions
  • assisting approval application placements within the framework of listing and non-cash capital increases
  • executing share buyback and employee participation programmes
  • as well as other technical handlings

Current references

Further references

No matching entries were found

ECM September 2022 Renewables / Cleantech

7C Solarparken / capital increase

More

ECM September 2022 Renewables / Cleantech

7C Solarparken / capital increase

More

ECM April 2022 Real Estate

DEFAMA / capital increase

More

ECM February 2022 Renewables / Cleantech

clearvise / capital increase

More

ECM December 2021 Other

Heliad Equity Partners GmbH & Co. KGaA / capital increase

More

ECM December 2021 Healthcare & Life Sciences

Medios AG / capital increase

More

ECM November 2021 Consumer Goods

Veganz Group AG / IPO

More

ECM October 2021 TMT

adesso SE / capital increase

More

ECM September 2021 Healthcare & Life Sciences

BRAIN Biotech / capital increase

More

ECM August 2021 Renewables / Cleantech

7C Solarparken / capital increase

More

To top